Kiromic BiopharmaInc Story
KRBPDelisted Stock | USD 1.45 0.00 0.00% |
Slightly above 56% of Kiromic BiopharmaInc's investor base is looking to short. The analysis of overall sentiment of trading Kiromic BiopharmaInc stock suggests that many investors are alarmed at this time. Kiromic BiopharmaInc's investor sentiment overview provides quick insight into current market opportunities from investing in Kiromic BiopharmaInc. The current market sentiment, together with Kiromic BiopharmaInc's historical and current headlines, can help investors time the market. In addition, many technical investors use Kiromic BiopharmaInc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Kiromic BiopharmaInc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Kiromic daily returns and investor perception about the current price of Kiromic BiopharmaInc as well as its diversification or hedging effects on your existing portfolios.
Kiromic |
Requested story not found. it has been either deleted or moved. View all stories for Kiromic BiopharmaInc.
Kiromic BiopharmaInc Latest Timeline
Kiromic BiopharmaInc is listed for 1.45. About 68.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 39.68. Kiromic BiopharmaInc had not issued any dividends in recent years. The entity had 1:30 split on the 13th of March 2023.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Kiromic BiopharmaInc information on this page should be used as a complementary analysis to other Kiromic BiopharmaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Kiromic Stock
If you are still planning to invest in Kiromic BiopharmaInc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic BiopharmaInc's history and understand the potential risks before investing.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |